Imfinzi plus Imjudo approved in Japan for advanced liver and non-small cell lung cancers ...

Retrieved on: 2022-12-28 07:11:14

Tags for this article:

Click the tags to see associated articles and topics

Imfinzi plus Imjudo approved in Japan for advanced liver and non-small cell lung cancers .... View article details on hiswai:

Excerpt

AstraZeneca's immunotherapies Imfinzi (durvalumab) and Imjudo (tremelimumab) have been approved in Japan for the treatment of three cancer types: ...

Article found on: news.cision.com